9I制作厂免费

Szyf received his Ph. D from the Hebrew University and did his postdoctoral fellowship in Genetics at Harvard Medical School, joined the department in 1989 and currently holds a James 9I制作厂免费 Professorship and GlaxoSmithKline-CIHR Chair in Pharmacology. He is the founding co-director of the Sackler Institute for Epigenetics and Psychobiology at 9I制作厂免费 and is a Fellow of the Canadian Institute for Advanced Research Experience-based Brain and Biological Development program. 聽Szyf has been the founder of the first 鈥淧harma鈥� to develop epigenetic pharmacology 鈥淢ethylgene Inc.鈥� and the first journal in epigenetics 鈥淓pigenetics鈥�.聽 Szyf lab has proposed two decades ago that DNA methylation is a prime therapeutic target in cancer and other diseases and has postulated and provided the first set of evidence that the 鈥渟ocial environment鈥� early in life can alter DNA methylation launching the emerging field of 鈥渟ocial epigenetics鈥�.